MOL-PCR and xMAP Technology

xMAP Technology: Applications in Detection of Pathogens

xMAP technology is applicable for high-throughput, multiplex and simultaneous detection of different analytes within a single complex sample. xMAP multiplex assays are currently available in various nucleic acid and immunoassay formats, enabling simultaneous detection and typing of pathogenic viruses, bacteria, parasites and fungi and also antigen or antibody interception. As an open architectu...

Test of ovarian cancer multiplex xMAP technology panel.

BACKGROUND An ovarian cancer marker panel including leptin, prolactin, osteopontin, insulin-like growth factor II (IGFII), macrophage migration inhibitory factor and CA125 was tested for multiplex marker measurement. Multiplex was compared to single assayed tumour markers: CA125, TPS, thymidine kinase, monototal and HE4. PATIENTS AND METHODS The serum marker levels in ovarian cancer patients ...

Bio-Rad’s Bio-Plex® suspension array system, xMAP technology overview

The Bio-Plex(®) system utilizes xMAP technology to permit the multiplexing of up to 100 different analytes. Multiplex analysis gives researchers the ability to look at analytes simultaneously providing more information from less sample volume in less time than traditional immunoassay methods. Similar to ELISA, xMAP utilizes an antibody sandwich for detection but differs from ELISA in capture su...

SECOND-GENERATION MULTIPLEX IMMUNOASSAYS xMAP Technology and Magnetic Appeal Put Multiplexing in the Fast Lane

Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology.

BACKGROUND Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers. METHODS We used a combination of in-house and commercially available multiplex immuno...